3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Breast Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Carcinoma, Intraductal, Noninfiltrating
2
Smoldering Multiple Myeloma
1
Polyps
1
Peripheral Nervous System Diseases
1
Monoclonal Gammopathy of Undetermined Significance
1
Malnutrition
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Dyspareunia
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Breast Neoplasms, Male
1
Breast Carcinoma In Situ
1
Interventions
Cyclophosphamide
155
Rituximab
148
Etoposide
84
fludarabine phosphate
73
Peripheral Blood Stem Cell Transplantation
68
Mycophenolic Acid
63
Busulfan
62
Filgrastim
59
Melphalan
58
Tacrolimus
54
Whole-Body Irradiation
51
Cytarabine
46
fludarabine
45
Radiotherapy
43
Methotrexate
41
Granulocyte Colony-Stimulating Factor
41
Cyclosporine
41
Vincristine
35
Antilymphocyte Serum
35
Carmustine
33
Doxorubicin
29
Prednisone
26
Thiotepa
25
Bendamustine Hydrochloride
24
Methylprednisolone
22
Ifosfamide
22
Dexamethasone
22
thymoglobulin
21
sargramostim
20
plerixafor
19
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Lymphoma, Non-Hodgkin
×
Fatty Acids, Omega-3
×
Clear all
NCT00455416
2008-05-21
KLYMF
Oslo University Hospital
Phase 2
Unknown
45 enrolled